TickerFacts.

Freenome, Inc. (FRNM): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$4.80M
As of 2025-12-31
-$6.30M
As of 2026-06-30
2024-12-31: -$2.12M2025-12-31: -$4.80M-$4.80M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$4.80Mn/m2026-03-12, Balance as of period end
2024-12-31-$2.12Mn/a2026-03-12, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Freenome, Inc. (FRNM)2025-12-31-$4.80Mn/m
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31$75.41M+57.7%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
CapForce Inc. (CFOR)2025-12-31$31.86M+331.6%
Personalis, Inc. (PSNL)2025-12-31$261.19M+28.7%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%
Celcuity Inc. (CELC)2025-12-31$100.56M-13.0%

Compare FRNM, BDSX, SERA, XGN side by side · Screen every company in Services-Medical Laboratories ↗